Abstract: According to one embodiment, a pulse wave velocity measuring device includes a first sensor, a second sensor, a base body and a calculation unit. The first sensor is configured to sense a pulse wave propagating through an interior of a vessel. The second sensor is separated from the first sensor and is configured to sense the pulse wave. The base body is configured to hold the first sensor and the second sensor and regulate a distance between the first sensor and the second sensor. The calculation unit is configured to derive a difference between a time of the sensing of the pulse wave by the first sensor and a time of the sensing of the pulse wave by the second sensor.

Abstract: The present invention provides a tumor screening marker that can be actually used in clinical practice to detect colorectal cancer, and a tumor progression marker that can complement CEA or CA19-9. Vitronectin for use as a tumor progression marker, a tumor screening marker or a prognostic prediction marker for colorectal cancer. A method of analyzing a vitronectin concentration in a collected blood sample. In the method, a measured value of vitronectin and a reference value of vitronectin are compared. Vitronectin is preferably used in combination with existing marker for colorectal cancer such as carcinoembryonic antigen and CA19-9.

Abstract: The present invention provides a tumor screening marker that can be actually used in clinical practice to detect colorectal cancer, and a tumor progression marker that can complement CEA or CA19-9. Galectin-1 used as a tumor screening marker or a tumor progression marker for colorectal cancer. Galectin-3 used as a tumor screening marker. Galectin-4 used as a tumor progression marker, a tumor screening marker, or a prognostic prediction marker for colorectal cancer. A method of analyzing the galectin concentration in a collected blood sample using the galectin. A colorectal cancer marker detection kit comprising a detection antibody selected from the group consisting of a fluorescently labeled galectin-1 antibody, a fluorescently labeled galectin-3 antibody, and a fluorescently labeled galectin-4 antibody.

Abstract: Provided is a cursor display method of displaying a cursor, indicating a focus point while being manipulatable to move, in a two-dimensional image in which sets of laser point cloud data distributed on a three-dimensional coordinate system are shown on the basis of a predetermined view point position. The cursor display method includes: performing arithmetic on a position on the three-dimensional coordinate system which corresponds to the focus point in the two-dimensional image; defining a predetermined plane graphic region, including the corresponding position and being orthogonal to a view point position direction, on the three-dimensional coordinate system on the basis of the corresponding position; dividing a view region, originating from the view point position passing through the plane graphic region, into segments on the basis of the plane graphic region; and performing non-display processing on sets of laser point cloud data placed in any one of the divided segments.

Abstract: According to an embodiment, a control filter coefficient is calculated in such a manner that a second spatial average of one or more complex sound pressure ratios at one or more target binaural positions when a first loudspeaker and a second loudspeaker emit a second acoustic signal and a first acoustic signal is approximated to a first spatial average of one or more complex sound pressure ratios at the one or more target binaural positions when a target virtual acoustic source emits the first acoustic signal.

Abstract: According to one embodiment, a sound field control apparatus is provided with a control filter and a calculation unit. The filter executes an FIR computation for an acoustic signal using coefficients to output a main signal and control signals. The unit calculates the main coefficient and the coefficients based on Spatial transmission characteristics and a sound increase factor n, to set a composite sound pressure from a main speaker and control speakers to a first area to be n times of a coming sound pressure from only the main speaker, and to set a composite sound pressure from the main speaker and control speakers to a second area to be equal to the coming sound pressure from only the main speaker.

Abstract: According to one embodiment, an acoustic reproduction device includes a loudspeaker unit, a loudspeaker rear chamber unit, and a port unit. The loudspeaker unit generates a sound wave. The loudspeaker rear chamber unit includes a chamber portion in which the loudspeaker unit is arranged, and at least one of a duct portion and a branch portion. The duct portion and the branch portion each have a volume, a cross-sectional area, and a length different from those of the chamber portion. A port unit is connected to the loudspeaker rear chamber unit and has a port to externally output a rear wave. The duct portion guides the rear wave from the loudspeaker unit up to the port unit.

Abstract: It is provided an insulin resistance marker, a method of evaluating insulin resistance, a method of screening a substance that improves insulin resistance, and a pharmaceutical composition for improving insulin resistance. An insulin resistance marker including a polypeptide comprising at least any 15 continuous amino acids in the specific amino acid sequence (sequence of a proepithelin protein). An insulin resistance marker including a polynucleotide selected from the group consisting of a polynucleotide comprising at least any 45 continuous bases in the base sequence encoding the above specific amino acid sequence, and a polynucleotide that is complementary to the polynucleotide.

Abstract: An information processing device and a mobile terminal include a power consumption calculator which calculates, for each processing executed by the information processing device (or mobile terminal), power consumption information concerning an amount of power consumed by executing each processing. A request generator compares the amount of power indicated by the power consumption information and a remaining amount of power of the information processing device(or mobile terminal), and generates a request to execute predetermined processing according to a result of the comparison. A request processor executes the predetermined processing in response to the generated request.

Abstract: According to one embodiment, a sound image localization apparatus includes following units. The first signal generating unit is configured to generate a first acoustic signal. The first speaker is configured to generate a first sound according to the first acoustic signal. The input unit is configured to input a localization magnification n. The first control filter unit is configured to adjust the first acoustic signal with a first control filter G1 calculated based on the input localization magnification n to generate a first adjusted acoustic signal. The second control filter unit is configured to adjust the first acoustic signal with a second control filter G2 calculated based on the input localization magnification n to generate a second adjusted acoustic signal. The second and third speakers are configured to generate second and third sounds according to the first and second adjusted acoustic signals, respectively.

Abstract: It is provided an insulin resistance marker, a method of evaluating insulin resistance, a method of screening a substance that improves insulin resistance, and a pharmaceutical composition for improving insulin resistance. An insulin resistance marker including a polypeptide comprising at least any 15 continuous amino acids in the specific amino acid sequence (sequence of a proepithelin protein). An insulin resistance marker including a polynucleotide selected from the group consisting of a polynucleotide comprising at least any 45 continuous bases in the base sequence encoding the above specific amino acid sequence, and a polynucleotide that is complementary to the polynucleotide.

Abstract: According to the present invention, a matrix reagent prepared by adding methylenediphosphonic acid (MDPNA) having two phosphonic acid groups as an additive to a matrix of 2,5-dihydroxybenzoic acid (DHBA) is used for the preparation of a sample. By using the sample according to the present invention, it is possible to achieve a higher peak intensity of phosphopeptide as compared with a sample in which DHBA is solely used as a matrix without using an additive, or a sample in which phosphoric acid (PA) is used as an additive in addition to DHBA. Further, use of the sample according to the present invention enables the detection of peptides that cannot be detected in a case of the phosphoric acid-added sample.

Abstract: A piezoelectric motor includes: a driven member having a substantially spherical shape; a base; a support member provided on the base; a gimbal frame that is provided on a periphery of the driven member; a first bearing that couples the gimbal frame to the support member to be rotatable around a first rotation axis; a second bearing that couples the driven member to the gimbal frame to be rotatable around a second rotation axis that is orthogonal to the first rotation axis; a plurality of piezoelectric elements, each of which has one end fixed onto the base and the other end disposed to be in contact with an actuation portion that abuts the driven member; and an elastic portion that is formed on the gimbal frame, the elastic portion being displaceable in a direction orthogonal to the first rotation axis and the second rotation axis.

Abstract: A piezoelectric motor includes: a plurality of piezoelectric units, respectively in contact with a driven target, disposed separately from each other, and configured to drive the driven target; and a magnet configured to apply a preload force to each of the plurality of piezoelectric units by magnetically attracting the driven target in the absence of direct contact with the driven target.

Abstract: In order to facilitate selection of an intended character from among a plurality of characters, a mobile phone includes a designated-position detecting portion (S01) for detecting a designated position, a moving direction detecting portion (S07) for detecting a moving direction of the detected position, a group selecting portion (S08), when the moving direction is detected, for selecting one of a plurality of character types into which the plurality of characters have been classified, on the basis of the moving direction, and a character selecting portion (S10, S15) for selecting one of at least one character classified in the selected character type.

Abstract: A deformable mirror device includes a substrate; a plurality of electrodes provided on the substrate; a spacer disposed on the substrate; a support member disposed above the spacer and having an opening passing through from a first face of the support member facing to the substrate to a second face of the support member opposite from the first face; a deformable electrode film formed below the first face of the support member so as to be opposed to the electrodes with a distance and so as to cover the opening; an insulation film provided between the deformable electrode film and the support member; and a reflection film provided on a face of the deformable electrode film opposite from the electrodes so as to overlap the opening. The electrodes are electrically insulated each other by a plurality of grooves radially extending from a region which includes a position corresponding to a center of the opening.

Abstract: A deformable mirror device includes a substrate; a plurality of electrodes provided on the substrate; a spacer disposed on the substrate; a support member disposed above the spacer and having an opening passing through from a first face of the support member facing to the substrate to a second face of the support member opposite from the first face; a deformable electrode film formed below the first face of the support member so as to be opposed to the electrodes with a distance and so as to cover the opening; an insulation film provided between the deformable electrode film and the support member; a reflection film provided on a face of the deformable electrode film opposite from the electrodes so as to overlap the opening; and a plurality of through holes passing through the reflection film and the deformable electrode film and disposed so as to overlap the opening.

Abstract: There is provided a flavor composition that can impart and augment the natural, fresh and milk-rich feeling of dairy products to a necessary and sufficient level, which is a flavor composition for milk, dairy products, foods or beverages containing milk and dairy products, or dairy product substitutes, characterized by containing a trace amount of one or more disulfide compounds selected from the group consisting of methyl 2-methyl-3-furyl disulfide, bis(2-methyl-3-furyl)disulfide, methyl furfuryl disulfide and difurfuryl disulfide, as dairy products to which the flavor composition is added.

Abstract: The present invention provides a tumor marker more highly specific to renal cancer. The present invention provides a method for identifying the morbidity of renal cancer. A tumor marker for renal cancer comprising proteins identified from renal cancerous tissue. A method for identifying the morbidity of renal cancer by using the tumor marker for renal cancer. The method comprises measuring the level of the protein in a sample derived from a person of interest who is to be examined to identify the morbidity of renal cancer; and comparing an obtained measured level to a normal level of the protein, wherein an upregulation or a downregulation of the obtained measured level compared to the normal level is used as one of indexes indicating that there is a high possibility that the person of interest has renal cancer.

Abstract: The present invention provides a tumor marker and a method capable of identifying the morbidity of colon cancer. A tumor marker including a protein identified from a colon cancer tissue. A method for identify the morbidity of colon cancer using the tumor marker. The method includes: measuring the level of the protein in a sample derived from a person of interest who should be examined to identify the morbidity of colon cancer; and comparing the measured level to the normal level of the protein, wherein a higher or lower measured level than the normal level is used as one indicator indicating that there is a high possibility that the person of interest has colon cancer.